Magdalena Harris

Magdalena Harris

Auto-generated profile, based on publicly available information

Magdalena Harris

London School of Hygiene and Tropical Medicine, London, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
MHMagdalena Harris
Magdalena Harris
TRTim Rhodes
Tim Rhodes
Evidence documents successful hepatitis C virus (HCV) treatment outcomes for people who inject drugs (PWID) and interest in HCV treatment among this population. Maximising HCV treatment for PWID can be an effective HCV preventative measure. Yet HCV treatment among PWID remains suboptimal. This review seeks to map social factors mediating HCV treatment access.

9 November 2019 in Addiction
Verified
Journal Article
Open access
PDF file
DLDan Lewer
Dan Lewer
JFJoseph Freer
Joseph Freer
EKEmma King
Emma King
SLSarah Larney
Sarah Larney
LDLouisa Degenhardt
Louisa Degenhardt
KMKatherine I. Morley
Katherine I. Morley
Aims: To summarize evidence on the frequency and predictors of health‐care utilization among people who use illicit drugs.Design: Systematic search of MEDLINE, EMBASE and PsychINFO for observational studies reporting health‐care utilization published between 1 January 2000 and 3 December 2018. We conducted narrative synthesis and meta‐analysis following a registered protocol (identifier: CRD42017076525).Setting and participants: People who use heroin, powder cocaine, crack cocaine, methamphetamine, amphetamine, ecstasy/3,4‐methyl​enedioxy​methamphetamine (MDMA), cannabis, hallucinogens or novel psychoactive substances; have a diagnosis of ‘substance use disorder’; or use drug treatment services.Measurements: Primary outcomes were the cumulative incidence (risk) and rate of care episodes in three settings: primary care, hospital admissions (in‐patient) and emergency department (ED).Findings: Ninety‐two studies were included, 84% from North America and Australia. Most studies focused on people using heroin, methamphetamine or crack cocaine, or who had a diagnosis of drug dependence. We were able to conduct a meta‐analysis of rates across 25 studies reporting ED episodes and 25 reporting hospital admissions, finding pooled rates of 151 [95% confidence interval (CI) = 114–201] and 41 (95% CI = 30–57) per 100 person‐years, respectively; on average 4.8 and 7.1 times more often than the general population. Heterogeneity was very high and was not explained by drugs used, country of study, recruitment setting or demographic characteristics. Predictors of health‐care utilization were consistent across studies and included unstable housing, drug injection and mental health problems. Opioid substitution therapy was consistently associated with reduced ED presentation and hospital admission. There was minimal research on health‐care utilization by people using ecstasy/MDMA, powder cocaine, hallucinogens or novel psychoactive substances.Conclusions: People who use illicit drugs are admitted to emergency department or hospital several times more often than the general population.

1 November 2013 in International Journal of Drug Policy
Verified
Journal Article
Closed access
MHMagdalena Harris
Magdalena Harris
TRTim Rhodes
Tim Rhodes

1 September 2020 in Social Science & Medicine
Verified
Journal Article
Open access
MHMagdalena Harris
Magdalena Harris
In the United Kingdom, increases in premature mortality among the intersecting populations of people made homeless and people who inject drugs map onto the implementation and solidification of fiscal austerity policies over the past decade, rather than drug market fluctuations and trends as in North America. In this context, it is crucial to explore how poverty, multi-morbidity and care delay interplay in exacerbating vulnerability to mortality among an aging population of people who use illicit drugs. The mixed methods Care & Prevent study generated survey data with 455 PWID and in-depth qualitative interviews with a subsample (n = 36). Participants were recruited though drug treatment services and homeless hostels in London from October 2017-June 2019. This paper focuses on qualitative findings, analysed thematically and contextualised in relation to the broader survey sample. Survey participants report an extensive history of rough sleeping (78%); injecting-related bacterial infections (65%) and related hospitalisation (30%). Qualitative accounts emphasise engagement with the medical system as a 'last resort', with admission to hospital in a critical or a "near death" condition common. For many severe physical pain and debility were normalised, incorporated into the day to day. In a context of everyday violence and marginalisation, avoidance of medical care can have a protective impetus. Translation of cultural safety principles to care for people who inject drugs in hospital settings offers transformative potential to reduce serious health harms among this population.

1 April 2013 in Social Science & Medicine
Verified
Journal Article
Closed access
MHMagdalena Harris
Magdalena Harris
TRTim Rhodes
Tim Rhodes
AMAnthea Martin
Anthea Martin

1 July 2013 in International Journal of Drug Policy
Verified
Journal Article
Closed access
JGJean-Paul C. Grund
Jean-Paul C. Grund
ALAlisher Latypov
Alisher Latypov
MHMagdalena Harris
Magdalena Harris